Bisdemethoxycurcumin
| Code | Size | Price |
|---|
| TAR-T6S1688-20mg | 20mg | £127.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
(1E,6E)-Bis(demethoxy)curcumin is a natural demethoxy derivative of curcumin,with anti-inflammatory and anti-cancer activities.
CAS:
33171-05-0
Formula:
C19H16O4
Molecular Weight:
308.33
Pathway:
Apoptosis; Autophagy;
Purity:
0.9992
SMILES:
Oc1ccc(/C=C/C(CC(/C=C/c(cc2)ccc2O)=O)=O)cc1
Target:
Apoptosis; Autophagy
References
Meng, Fu, Shuilian, et al. Inhibitory effects of bisdemethoxycurcumin on mast cell-mediated allergic diseases.[J]. International immunopharmacology, 2018.
Jin Y, Chen X, Gao Z, et al. Bisdemethoxycurcumin alleviates vandetanib-induced cutaneous toxicity in vivo and in vitro through autophagy activation. Biomedicine & Pharmacotherapy. 2021, 144: 112297.
Ramezani M , Hatamipour M , Sahebkar A . Promising Anti-tumor properties of Bisdemethoxycurcumin: A Naturally Occurring Curcumin Analogue[J]. Journal of Cellular Physiology, 2017.